Osimertinib Mesylate

Osimertinib Mesylate
  • Name: AZD-9291 (Mesylate); Tagrisso; Osimertinib Mesylate
  • Catalog No.: CPDB0137
  • CAS No.: 1421373-66-1
  • Molecular Weight: 595.72
  • Chemical Formula: C29H37N7O5S
  • For scientific research only, not for patients.

    Product Detail

    Product Tags

    Pack Size Availability Price (USD)
    500mg In Stock 100
    1g In Stock 180
    5g In Stock 600
    More Sizes Get Quotes Get Quotes

    Chemical Name:

    N-(2-((2-(dimethylamino)ethyl)(methyl)amino)-4-methoxy-5-((4-(1-methyl-1H-indol-3-yl)pyrimidin-2-yl)amino)phenyl)acrylamide mesylate

    SMILES Code: 

    CN(CCN(C)C)C1=CC(OC)=C(C=C1NC(C=C)=O)NC2=NC=CC(C3=CN(C)C4=C3C=CC=C4)=N2.OS(=O)(C)=O

    InChi Code:

    InChI=1S/C28H33N7O2.CH4O3S/c1-7-27(36)30-22-16-23(26(37-6)17-25(22)34(4)15-14-33(2)3)32-28-29-13-12-21(31-28)20-18-35(5)24-11-9-8-10-19(20)24;1-5(2,3)4/h7-13,16-18H,1,14-15H2,2-6H3,(H,30,36)(H,29,31,32);1H3,(H,2,3,4)

    InChi Key:

    FUKSNUHSJBTCFJ-UHFFFAOYSA-N

    Keyword:

    AZD-9291, AZD9291, AZD 9291, Tagrisso,Osimertinib Mesylate, 1421373-66-1

    Solubility: Soluble in DMSO

    Storage: 0 - 4°C for short term (days to weeks), or -20°C for long term (months)

    Description: 

    Osimertinib, also known as mereletinib and AZD-9291, is a third-generation EGFR inhibitor, showed promise in preclinical studies and provides hope for patients with advanced lung cancers that have become resistant to existing EGFR inhibitors. AZD9291 is highly active in preclinical models and is well tolerated in animal models. It inhibits both activating and resistant EGFR mutations while sparing the normal form of EGFR that is present in normal skin and gut cells, thereby reducing the side effects encountered with currently available medicines. Osimertinib was approved on Nov. 2015.

    Target: EGFR


  • Previous:
  • Next:

  • Related Products

    
    WhatsApp Online Chat !